全球乳癌診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計乳癌診斷市場將從 2025 年的 43.2 億美元成長到 2034 年的 86.2 億美元，2026 年至 2034 年的複合年成長率為 7.98%。

由於乳癌發生率不斷上升以及早期檢測的重要性日益凸顯，全球乳癌診斷市場正快速成長。乳房X光檢查、超音波、磁振造影和切片檢查等診斷技術被廣泛用於識別和評估乳癌。人們對定期體檢和預防醫學意識的提高，促使更多人接受早期診斷檢測。

影像學和分子診斷技術的進步正在提高乳癌檢測的準確性和效率。數位乳房X光攝影、3D乳房攝影和生物標記檢測正在幫助醫療專業人員更早發現癌症，從而製定更有效的治療方案。醫療機構也正在投資先進的診斷設備，以加強其癌症篩檢計畫。

隨著各國政府和醫療機構大力進行乳癌防治宣傳活動和篩檢工作，市場預計將持續擴張。癌症診斷和個人化醫療研究的進步將進一步提升檢測能力。由於早期診斷已成為癌症治療的關鍵環節，對先進乳癌診斷技術的需求也將持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球乳癌診斷市場：按類型分類

• 市場分析、洞察與預測
• 診斷影像
• 切片檢查
• 基因組檢測
• 驗血
• 其他

第5章 全球乳癌診斷市場：依產品分類

• 市場分析、洞察與預測
• 基於平台的產品
• 診斷影像

第6章 全球乳癌診斷市場：依應用分類

• 市場分析、洞察與預測
• 篩檢
• 診斷與預測
• 預後
• 研究

第7章：全球乳癌診斷市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和診所
• 醫學檢查室和診斷中心
• 其他

第8章 全球乳癌診斷市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Hologic Inc
  • Genomic Health（Exact Sciences Corporation）
  • BD
  • Danaher
  • Koninklijke Philips NV
  • QIAGEN
  • Thermo Fisher Scientific Inc
  • Argon Medical Devices Inc
  • Myriad Genetics
  • F. Hoffmann-La Roche Ltd

The Breast Cancer Diagnostics Market size is expected to reach USD 8.62 Billion in 2034 from USD 4.32 Billion (2025) growing at a CAGR of 7.98% during 2026-2034.

The global breast cancer diagnostics market is growing rapidly due to the increasing incidence of breast cancer and the rising importance of early detection. Diagnostic technologies such as mammography, ultrasound, MRI, and biopsy testing are widely used to identify and evaluate breast tumors. Growing awareness about routine screening and preventive healthcare is encouraging more individuals to undergo early diagnostic testing.

Technological advancements in imaging and molecular diagnostics are improving the accuracy and efficiency of breast cancer detection. Digital mammography, 3D breast imaging, and biomarker testing are helping healthcare professionals identify cancer at earlier stages, enabling more effective treatment planning. Healthcare institutions are also investing in advanced diagnostic equipment to enhance cancer screening programs.

The market is expected to continue expanding as governments and healthcare organizations promote breast cancer awareness campaigns and screening initiatives. Increasing research in cancer diagnostics and personalized medicine will further enhance detection capabilities. As early diagnosis becomes a critical component of cancer care, demand for advanced breast cancer diagnostic technologies will continue to grow.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Imaging
• Biopsy
• Genomic Tests
• Blood Tests
• Others

By Product

• Platform-Based Products
• Imaging

By Application

• Screening
• Diagnostic & Predictive
• Prognostic
• Research

By End Use

• Hospitals & Clinics
• Medical Labs & Diagnostics Centers
• Others

COMPANIES PROFILED

• Hologic Inc, Genomic Health Exact Sciences Corporation, BD, Danaher, Koninklijke Philips NV, QIAGEN, Thermo Fisher Scientific Inc, Argon Medical Devices Inc, Myriad Genetics, F HoffmannLa Roche Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BREAST CANCER DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Genomic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Blood Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BREAST CANCER DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Platform-Based Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BREAST CANCER DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic & Predictive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Prognostic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BREAST CANCER DIAGNOSTICS MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Medical Labs & Diagnostics Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BREAST CANCER DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Product
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Product
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Product
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Product
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Product
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BREAST CANCER DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Hologic Inc
  • 10.2.2 Genomic Health (Exact Sciences Corporation)
  • 10.2.3 BD
  • 10.2.4 Danaher
  • 10.2.5 Koninklijke Philips N.V
  • 10.2.6 QIAGEN
  • 10.2.7 Thermo Fisher Scientific Inc
  • 10.2.8 Argon Medical Devices Inc
  • 10.2.9 Myriad Genetics
  • 10.2.10 F. Hoffmann-La Roche Ltd